The glycan-binding protein galectin-9 has direct apoptotic activity toward melanoma cells

Journal of Investigative Dermatology

Volumn 132, Issue 9, 2012, Pages 2302-2305

  Wiersma, Valerie R ^a   De Bruyn, Marco ^a   Van Ginkel, Robert J ^a   Sigar, Emily ^a   Hirashima, Mitsuomi ^b   Niki, Toshiro ^c   Nishi, Nozomu ^d   Samplonius, Douwe F ^a   Helfrich, Wijnand ^a   Bremer, Edwin ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b KAGAWA UNIVERSITY   (Japan)

^c GalPharma Co   (Japan)

^d KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ECALECTIN;

APOPTOSIS; CANCER INHIBITION; CYTOTOXICITY; DRUG ACTIVITY; HUMAN; LETTER; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 84865325390     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.133     Document Type: Letter

References (9)

1. Barrow H, Guo X, Wandall HH et al. (2011) Serum galectin-2, -4, and -8 Are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium. Clin Cancer Res 17:7035-46
2. Cederfur C, Salomonsson E, Nilsson J et al. (2008) Different affinity of galectins for human serum glycoproteins: galectin-3 binds many protease inhibitors and acute phase proteins. Glycobiology 18:384-94
3. Hahn HP, Pang M, He J et al. (2004) Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death. Cell Death Differ 11:1277-86
4. Irie A, Yamauchi A, Kontani K et al. (2005) Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer. Clin Cancer Res 11:2962-8
5. Kageshita T, Kashio Y, Yamauchi A et al. (2002) Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int J Cancer 99:809-16
6. Liang M, Ueno M, Oomizu S et al. (2008) Galectin-9 expression links to malignant potential of cervical squamous cell carcinoma. J Cancer Res Clin Oncol 134: 899-907
7. Nobumoto A, Nagahara K, Oomizu S et al. (2008) Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices. Glycobiology 18:735-44
8. Wiersma VR, de Bruyn M, HelfrichWet al. (2011) Therapeutic potential of Galectin-9 in human disease. Med Res Rev; e-pub ahead of print 26 July 2011
9. Yamauchi A, Kontani K, Kihara M et al. (2006) Galectin-9, a novel prognostic factor with antimetastatic potential in breast cancer. Breast J 12:S196-200